Counterfeit Drugs: What the Doctor Didn't Order

Delay at the FDA
The US Food and Drug Administration has come under criticism recently...

Beating the Big C
The global market for cancer drugs is growing rapidly, but are we any...

Reality Bites: Disappointment in the R&D Sector
The pharmaceuticals industry is investing twice as much in R&D as it was...

Amendments Set to Clear Ambiguity
The US government is imposing transparency rules on the relationship...

The Witty Answer to GSK's Future
Has Andrew Witty got what it takes to keep GlaxoSmithKline at the top?...